Belite Bio (BLTE) Other Gross PP&E Adjustments (2021 - 2025)
Belite Bio's quarterly Other Gross PP&E Adjustments came in at -$1.6 million in Q4 2025, down 145.69% year-on-year from $3.6 million in Q4 2024, and down 145.69% quarter-over-quarter from -$661000.0 in Q4 2024.
Belite Bio has reported Other Gross PP&E Adjustments for 5 years, with the latest figure at -$1.6 million in Q4 2025.
- For the quarter ending Q4 2025, Other Gross PP&E Adjustments fell 145.69% year-over-year to -$1.6 million; the trailing twelve-month figure through Dec 2025 stood at -$1.6 million (down 145.69% YoY), and the FY2025 full-year result was -$1.6 million, down 145.69% from the prior year.
- Other Gross PP&E Adjustments for Q4 2025 stood at -$1.6 million, down from -$661000.0 in the prior quarter.
- The five-year high for Other Gross PP&E Adjustments was -$384000.0 in Q4 2021, with the low at -$1.6 million in Q4 2025.
- Average Other Gross PP&E Adjustments over 5 years is -$912400.0, with a median of -$886000.0 recorded in 2022.
- Year-over-year, Other Gross PP&E Adjustments surged 34.36% in 2024 and plunged 145.69% in 2025.
- Tracing BLTE's Other Gross PP&E Adjustments over 5 years: stood at -$384000.0 in 2021, then slumped by 130.73% to -$886000.0 in 2022, then slipped by 13.66% to -$1.0 million in 2023, then surged by 34.36% to -$661000.0 in 2024, then sank by 145.69% to -$1.6 million in 2025.
- The last three Other Gross PP&E Adjustments figures came in at -$1.6 million (Q4 2025), -$661000.0 (Q4 2024), and -$1.0 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Belite Bio | 4.92 Bn | 4.45 Bn | - | -1.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.62 Mn |
| Dec 31, 2025 | -1.62 Mn |
| Sep 30, 2025 | -509,000.00 |
| Sep 30, 2025 | -509,000.00 |
| Dec 31, 2024 | -661,000.00 |
| Dec 31, 2024 | -661,000.00 |
| Dec 31, 2023 | -1.01 Mn |
| Dec 31, 2023 | -1.01 Mn |
| Dec 31, 2022 | -886,000.00 |
| Dec 31, 2022 | -886,000.00 |
| Dec 31, 2021 | -384,000.00 |
| Dec 31, 2021 | -384,000.00 |